DREAM Project Community Health Worker Intervention



Status:Completed
Conditions:Diabetes, Diabetes
Therapuetic Areas:Endocrinology
Healthy:No
Age Range:25 - 85
Updated:10/20/2017
Start Date:July 1, 2009
End Date:February 25, 2016

Use our guide to learn which trials are right for you!

The DREAM (Diabetes Research, Education, and Action for Minorities) Project is a Community
Health Worker (CHW) intervention to improve diabetic management and control among
Bangladeshis with diabetes in New York City (NYC).

The DREAM (Diabetes Research, Education, and Action for Minorities) Project is a Community
Health Worker (CHW) intervention to improve diabetic management and control among
Bangladeshis with diabetes in New York City (NYC). For a two-arm, randomized controlled trial
(RCT), investigators will recruit a sample of 256 participants, all of whom are 1) of
Bangladeshi descent, 2) residing in NYC, 3) diagnosed with Type 2 diabetes mellitus (T2DM)
and a recent Hemoglobin A1c (HbA1c) of ≥ 6.5, and 4) between the ages of 21-85. The treatment
group receives a six-month CHW-led intervention consisting of five monthly group educational
sessions, two one-on-one visits, and follow-up phone calls as needed from a CHW. The control
group receives an introductory educational session only. Primary and secondary outcomes
include clinical and behavioral measures, such as HbA1c and weight change, access to and
utilization of care (i.e. appointment keeping and use of specialty care), and knowledge and
practice of physical activity and healthful eating. Additionally, information regarding CHW
characteristics, the processes and mechanisms for influencing healthful behavior change, and
fidelity of the intervention are collected. Outcomes are measured at Baseline, 3-Months,
6-Months for both groups, and at 12-Months for the treatment group.

Inclusion Criteria:

- confirmed clinical diagnosis of T2DM with a Hemoglobin A1c (HbA1c) of ≥ 6.5%; and

- male or female between the ages of 21-85 years old; and

- willingness to be randomized to either treatment or control groups.

Exclusion Criteria:

- is or was on renal dialysis;

- experiencing an acute or terminal illness or serious mental illness;

- had a history of recent coronary event within the last 3 months of recruitment;

- is pregnant at the time of recruitment;

- experienced other severe medical conditions that might preclude participation;

- has poor short-term prognosis (expected death in <2 years); or

- is participating in another research study.
We found this trial at
1
site
New York, New York 10016
Principal Investigator: Nadia Islam, PhD
?
mi
from
New York, NY
Click here to add this to my saved trials